Healthcare Equipment and Supplies
Company Overview of Cordis Corporation
Cordis Corporation, through its subsidiaries, develops, manufactures, and distributes drug-eluting stents, catheters, and guide wires for interventional medicine, minimally invasive computer-based imaging, and electrophysiology applications. The company offers a portfolio of access, diagnostic, and interventional medical products for use in cardiovascular, endovascular, and biliary duct (liver) obstructive interventional procedures. Its cardiology products include transradial solutions for radial access procedures; diagnostic products, such as access kits, sheath introducers, diagnostic guide wires, and diagnostic catheters; guiding and PTCA dilatation catheters; and steerable guide wires an...
6500 Paseo Padre Parkway
Fremont, CA 94555
Founded in 1959
Key Executives for Cordis Corporation
Vice President of Worldwide Clinical Research & Operations
Chief Scientific Officer and Global Head of Research & Development
Vice President of Regulatory Affairs and Quality Assurance
Vice President of Latin American Operations
Vice President of Corporate Relations and Assistant Secretary
Compensation as of Fiscal Year 2015.
Cordis Corporation Key Developments
Wi-Lan Inc. Enters into Settlement, License Agreement with Codman & Shurtleff, Cordis Corporation
Jul 6 15
Wi-Lan (WILN) announced that it has entered into a settlement and license agreement with Codman & Shurtleff, Inc. and Cordis Corporation resolving the patent litigation that was pending in the United States District Court for the Central District of California.
Back Bay Medical Inc., Enters into Settlement and License Agreement with Codman & Shurtleff, Inc. and Cordis Corporation
Jul 6 15
WiLAN announced that the company's subsidiary, Back Bay Medical Inc., has entered into a settlement and license agreement with Codman & Shurtleff, Inc. and Cordis Corporation. The agreement resolves litigation that was pending in the United States District Court for the Central District of California.
Cordis Corporation Announces Launch of New ELITECROSS Support Catheter and OUTBACK Elite Re-Entry Catheter
Jun 8 15
Cordis Corporation announced launch of the new ELITECROSS Support Catheter in the United States and OUTBACK Elite Re-Entry Catheter in the United States, Europe and Japan. This expansion of the CORDIS Crossing Portfolio for treatment of chronic total occlusions (CTO) further underlines the company's decade-long commitment to the space. The new products will add to a suite of specialty and workhorse solutions designed to support physicians in crossing the most complex lesions with control and confidence. A chronic total occlusion (CTO) occurs when the accumulation of plaque becomes so severe that it results in a complete (or nearly complete) blockage of the vessel. When this occurs, physicians must find a way to cross the occlusion in order to complete treatment of the lesion using interventional techniques. The CORDIS Crossing Portfolio reduces the complexity of challenging cases and provides a comprehensive crossing solution of specialty and workhorse devices. The new ELITECROSS Support Catheter family provides unparalleled support and pushability to help get to and through complex lesions. The catheter features a braided shaft, tapered tip, lubricious hydrophilic coating and ultra low-friction inner lumen to enhance trackability over the guidewire. The ELITECROSS Support Catheter is designed to provide additional support to the distal portion of diagnostic or interventional devices, and is compatible with the FRONTRUNNER® XP CTO Catheter as well as other ancillary devices. The redesigned OUTBACK Elite Re-Entry Catheter enables faster and more precise re-entry into the true lumen in the most challenging cases, and represents the first ever re-entry device available in Japan. With a focus on control and precision, the OUTBACK Elite Catheter was redesigned with an ergonomic handle and torque control location enabling single-handed operation by the user. The addition of an 80 cm shaft length will aid in optimizing procedures by reducing the length of shaft outside the patient. These new features combined with a redesigned package make the OUTBACK Elite Re-Entry Catheter a more convenient, precision re-entry tool for the toughest lesions of peripheral vascular disease. In a recent study by Gandini et al., the OUTBACK Re-Entry Catheter was shown to have a higher success rate of precision re-entry versus manual wire techniques.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|